Home
>
National Drug Code (NDC)
>
Catapres
Catapres - 0597-0031-34 - (clonidine)
Drug Information of Catapres
| Product NDC: | 0597-0031 |
| Proprietary Name: | Catapres |
| Non Proprietary Name: | clonidine |
| Active Ingredient(s): | .1 mg/24h & nbsp; clonidine |
| Administration Route(s): | TRANSDERMAL |
| Dosage Form(s): | PATCH, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Catapres
| Product NDC: | 0597-0031 |
| Labeler Name: | Boehringer Ingelheim Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018891 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19851001 |
Package Information of Catapres
| Package NDC: | 0597-0031-34 |
| Package Description: | 4 POUCH in 1 CARTON (0597-0031-34) > 1 PATCH in 1 POUCH > 24 h in 1 PATCH |
NDC Information of Catapres
| NDC Code | 0597-0031-34 |
| Proprietary Name | Catapres |
| Package Description | 4 POUCH in 1 CARTON (0597-0031-34) > 1 PATCH in 1 POUCH > 24 h in 1 PATCH |
| Product NDC | 0597-0031 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | clonidine |
| Dosage Form Name | PATCH, EXTENDED RELEASE |
| Route Name | TRANSDERMAL |
| Start Marketing Date | 19851001 |
| Marketing Category Name | NDA |
| Labeler Name | Boehringer Ingelheim Pharmaceuticals Inc. |
| Substance Name | CLONIDINE |
| Strength Number | .1 |
| Strength Unit | mg/24h |
| Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
